
Several companies reported their first-quarter 2025 earnings results, with many exceeding analyst expectations. Pegasystems (NASDAQ: PEGA) reported adjusted earnings per share of $1.53, surpassing the estimate of $0.49, and sales of $475.6 million, beating the $356.6 million forecast. The company’s stock rose sharply, supported by a 21% increase in total backlog, its fastest growth in over 12 quarters. Amphenol (NYSE: APH) posted adjusted EPS of $0.63, above the $0.52 estimate, and revenue of $4.81 billion, exceeding the $4.23 billion consensus. The company experienced 58% EPS growth and record margins, with its IT segment growing 132% year-over-year. Plexus reported Q2 GAAP EPS of $1.41, slightly above the $1.39 estimate, but missed sales expectations with $980 million versus $981.2 million. Its Q3 adjusted EPS guidance ranges from $1.65 to $1.80, near the $1.70 estimate, and sales guidance between $1 billion and $1.04 billion, slightly below the $1.03 billion forecast. Ameriprise Financial reported Q1 adjusted EPS of $9.50, beating the $9.11 estimate, but sales of $4.35 billion missed the $4.40 billion forecast. L3Harris Technologies posted adjusted EPS of $2.41, beating the $2.32 estimate, with sales of $5.13 billion falling short of the $5.22 billion estimate. The company lowered its full-year 2025 adjusted EPS guidance to $10.30-$10.50 from $10.55-$10.85 and sales guidance to $21.40 billion-$21.70 billion from $21.80 billion-$22.20 billion, both below analyst expectations. Allegion reported adjusted EPS of $1.86, beating the $1.67 estimate, and sales of $941.9 million, surpassing the $919.6 million forecast.


$ALLE Allegion Q1 Adj. EPS $1.86 Beats $1.67 Estimate Sales $941.90M Beat $919.64M Estimate
L3Harris Technologies Reports First Quarter 2025 Results, Updates 2025 Guidance https://t.co/Ix9VFU1EE7 https://t.co/37nxj7Uly4
$LHX L3Harris Technologies Q1 Adj. EPS $2.41 Beats $2.32 Estimate Sales $5.13B Miss $5.22B Estimate Lowers FY2025 Adj EPS Guidance from $10.55-$10.85 to $10.30-$10.50 vs $10.61 Est Lowers FY2025 Sales Guidance from $21.80B-$22.20B to $21.40B-$21.70B vs $21.89B Est